Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
10.3851/IMP2475
Saved in:
Main Authors: | Seo, S., Englund, J.A., Nguyen, J.T., Pukrittayakamee, S., Lindegardh, N., Tarning, J., Tambyah, P.A., Renaud, C., Went, G.T., De Jong, M.D., Boeckh, M.J. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/125373 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
by: Sachiko Seo, et al.
Published: (2018) -
Pharmacokinetics of high-dose oseltamivir in healthy volunteers
by: Y. Wattanagoon, et al.
Published: (2018) -
Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
by: Podjanee Jittamala, et al.
Published: (2018) -
Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers
by: Insti Instiaty, et al.
Published: (2018) -
Effect of dietary purines on the pharmacokinetics of orally administered ribavirin
by: Li, L., et al.
Published: (2011)